Список проголосовавших за комментарий "Мольберт Чебурага, <br/> <br/> It was recently announced Sorrento had partnered with New York-based health care system Mount Sinai to develop an antibody cocktail. Dubbed Covi-Shield, the cocktail will be comprised of three different antibodies and, <strong>pending FDA approval</strong>, will be used as a prophylactic treatment for people returning to work and those who have been exposed to COVID-19.<br/> <br/> То есть даже FDA по упрощенной процедуре (EUA) еще не одобрило.<br/> Пока просто новость. Сколько таких хайпов уже было."